Well it was reasonable for OIL to provide us with the good news of technology use in cancer research in NY before the interim result. However I'm sure anyone who bought on the strength of these announcements is starting to wonder when the directors became aware of the deferral of deliveries to Zeiss. In the short term this appears to have had the largest impact on the share price.
